Literature DB >> 23380763

Resveratrol decreases noise-induced cyclooxygenase-2 expression in the rat cochlea.

Michael D Seidman1, Wenxue Tang, Venkatesh Uma Bai, Nadir Ahmad, Hao Jiang, Joseph Media, Nimisha Patel, Cory J Rubin, Robert T Standring.   

Abstract

OBJECTIVE: Our previous studies have demonstrated the efficacy of resveratrol, a grape constituent noted for its antioxidant and anti-inflammatory properties, in reducing temporary threshold shifts and decreasing cochlear hair cell damage following noise exposure. This study was designed to identify the potential protective mechanism of resveratrol by measuring its effect on cyclooxygenase-2 (COX-2) protein expression and reactive oxygen species (ROS) formation following noise exposure. STUDY
DESIGN: Controlled animal intervention study.
SETTING: Otology Laboratory, Henry Ford Health System. SUBJECTS AND METHODS: Twenty-two healthy male Fischer 344 rats (2-3 months old) were exposed to acoustic trauma of variable duration with or without intervention. An additional 20 healthy male rats were used to study COX-2 expression at different time points during and following treatment of 24 hours of noise exposure. Cochlear harvest was performed at various time intervals for measurement of COX-2 protein expression via Western blot analysis and immunostaining. Peripheral blood was also obtained for ROS analysis using flow cytometry.
RESULTS: Acoustic trauma exposure resulted in a progressive up-regulation of COX-2 protein expression, commencing at 8 hours and peaking at 32 hours. Similarly, ROS production increased after noise exposure. However, treatment with resveratrol reduced noise-induced COX-2 expression as well as ROS formation in the blood as compared with the controls.
CONCLUSION: COX-2 levels are induced dramatically following noise exposure. This increased expression may be a potential mechanism of noise-induced hearing loss (NIHL) and a possible mechanism of resveratrol's ability to mitigate NIHL by its ability to reduce COX-2 expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23380763     DOI: 10.1177/0194599813475777

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  9 in total

Review 1.  Biological therapies in otology.

Authors:  A Roemer; H Staecker; S Sasse; T Lenarz; A Warnecke
Journal:  HNO       Date:  2017-08       Impact factor: 1.284

2.  [Biological therapies in otology. German version].

Authors:  A Roemer; H Staecker; S Sasse; T Lenarz; A Warnecke
Journal:  HNO       Date:  2017-07       Impact factor: 1.284

3.  Effect of myricetin on the gene expressions of NOX3, TGF-β1, prestin, and HSP-70 and anti-oxidant activity in the cochlea of noise-exposed rats.

Authors:  Maryam Bahaloo; Mohammad Ebrahim Rezvani; Ehsan Farashahi Yazd; Fatemeh Zare Mehrjerdi; Mohammad Hossein Davari; Ali Roohbakhsh; Abolfazl Mollasadeghi; Haniyeh Nikkhah; Maryam Vafaei; Amir Houshang Mehrparvar
Journal:  Iran J Basic Med Sci       Date:  2020-05       Impact factor: 2.699

4.  Resveratrol Ameliorates Lipopolysaccharide-Induced Sudden Sensorineural Hearing Loss in In Vitro Model through Multitarget Antiapoptotic Mechanism Based on Network Pharmacology and Molecular Docking.

Authors:  Shiming Ye; Jing Liu; Qi Dong; Xinxin Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-19       Impact factor: 2.650

Review 5.  Early investigational drugs for hearing loss.

Authors:  Debashree Mukherjea; Sumana Ghosh; Puspanjali Bhatta; Sandeep Sheth; Srinivasan Tupal; Vikrant Borse; Thomas Brozoski; Kelly E Sheehan; Leonard P Rybak; Vickram Ramkumar
Journal:  Expert Opin Investig Drugs       Date:  2014-09-22       Impact factor: 6.206

Review 6.  MicroRNAs in Hearing Disorders: Their Regulation by Oxidative Stress, Inflammation and Antioxidants.

Authors:  Kedar N Prasad; Stephen C Bondy
Journal:  Front Cell Neurosci       Date:  2017-09-11       Impact factor: 5.505

7.  The Effect of Antioxidant Supplementation in Patients with Tinnitus and Normal Hearing or Hearing Loss: A Randomized, Double-Blind, Placebo Controlled Trial.

Authors:  Anna I Petridou; Eleftheria T Zagora; Petros Petridis; George S Korres; Maria Gazouli; Ioannis Xenelis; Efthymios Kyrodimos; Georgia Kontothanasi; Andriana C Kaliora
Journal:  Nutrients       Date:  2019-12-12       Impact factor: 5.717

8.  Polydatin activates the Nrf2/HO-1 signaling pathway to protect cisplatin-induced hearing loss in guinea pigs.

Authors:  Dafei Li; Haiyan Zhao; Piao Xu; Qiongping Lin; Tingting Zhao; Chubing Li; Zhong-Kai Cui; Guangyong Tian
Journal:  Front Pharmacol       Date:  2022-08-04       Impact factor: 5.988

9.  Inhibition of cyclooxygenase-2 by NS398 attenuates noise-induced hearing loss in mice.

Authors:  Yu Sun; Jintao Yu; Xi Lin; Wenxue Tang
Journal:  Sci Rep       Date:  2016-03-03       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.